SymBio Pharmaceuticals Limited
4582 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 港区虎ノ門四丁目１番２８号
- Website:
- https://www.symbiopharma.com/en/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
SymBio Pharmaceuticals Limited is a Japan-based biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with cancer and other serious diseases. The company focuses on addressing unmet medical needs by providing effective prescription drugs, tailored to enhance treatment outcomes. With a commitment to research and development, SymBio collaborates with global partners to bring advanced pharmaceutical products to the Japanese market. By prioritizing the well-being of patients and healthcare professionals, SymBio aims to improve quality of life through its specialized medical solutions.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-21 03:23 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 36.1 KB | |
| 2025-04-18 09:38 |
Regulatory News Service
訂正臨時報告書
|
Japanese | 40.4 KB | |
| 2025-03-26 05:29 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 207.2 KB | |
| 2025-03-26 05:04 |
Inside Information Statement
臨時報告書
|
Japanese | 26.2 KB | |
| 2025-03-25 07:35 |
Inside Information Statement
臨時報告書
|
Japanese | 44.1 KB | |
| 2025-03-25 07:34 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 312.0 KB | |
| 2025-03-25 07:32 |
Internal Control over Financial Reporting
内部統制報告書－第20期(2024/01/01－2024/12/31)
|
Japanese | 23.9 KB | |
| 2025-03-25 07:31 |
Regulatory News Service
確認書
|
Japanese | 9.0 KB | |
| 2025-03-25 07:30 |
Annual Report
有価証券報告書－第20期(2024/01/01－2024/12/31)
|
Japanese | 1.9 MB | |
| 2025-02-20 08:20 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 241.9 KB | |
| 2025-02-06 07:39 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 264.1 KB | |
| 2025-01-20 07:40 |
Regulatory News Service
訂正有価証券届出書（参照方式）
|
Japanese | 297.4 KB | |
| 2024-12-25 08:39 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 401.0 KB | |
| 2024-12-25 08:38 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 400.2 KB | |
| 2024-12-25 08:37 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 399.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
EQL Pharma AB | Sweden | EQL | |
| E.S. Australia Israel Holdings LTD | Israel | AUIS | ||
|
EuroAPI | France | EAPI | |
|
Eurofins-Cerep | France | ALECR | |
|
EUROPEAN GREEN TRANSITION PLC | United Kingdom | EGT | |
|
Evolear AB | Sweden | EVOL | |
|
Faes Farma S.A. | Spain | FAE | |
|
Fagron N.V. | Belgium | FAGR | |
|
Farmak | Ukraine | FARM | |
|
Farmsintez ao | Russian Federation | LIFE |